Tranzyme Inc (TZYM.OQ)
TZYM.OQ on NASDAQ Stock Exchange Global Market
0.60USD
24 May 2013
0.60USD
24 May 2013
Price Change (% chg)
$0.01 (+1.71%)
$0.01 (+1.71%)
Prev Close
$0.59
$0.59
Open
$0.60
$0.60
Day's High
$0.62
$0.62
Day's Low
$0.60
$0.60
Volume
54,750
54,750
Avg. Vol
147,981
147,981
52-wk High
$5.15
$5.15
52-wk Low
$0.40
$0.40
About
Tranzyme, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing mechanism-based therapeutics for the treatment of upper gastrointestinal (GI) motility disorders. The Company is developing TZP-102, an oral ghrelin agonist for treating the symptoms associated with chronic upper... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $16.92 |
| Shares Outstanding (Mil.): | 27.60 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| TZYM.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 46.63 | 34.30 |
| EPS (TTM): | -0.68 | -- | -- |
| ROI: | -74.84 | 1.55 | 18.43 |
| ROE: | -126.72 | 2.77 | 19.30 |
BRIEF-Tranzyme shares up 5.5 percent in premarket
NEW YORK, Feb 8 - Tranzyme Inc : * Shares up 5.5 percent in premarket, to explore sale of company
CORRECTED-UPDATE 1-Tranzyme to explore sale of company
(Corrects paragraph 4 to say drug was in mid-stage trials, not late stage)
Tranzyme to explore strategic options
- Drugmaker Tranzyme Inc said it will explore strategic options, including a sale, less than two months after it stopped the second mid-stage trial of its drug for stomach paralysis.
Tranzyme to explore strategic options
Feb 8 - Drugmaker Tranzyme Inc said it will explore strategic options, including a sale, less than two months after it stopped the second mid-stage trial of its drug for stomach paralysis.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

